1 year return (CAGR)
-
Tvardi Therapeutics, Inc. Exchange (NASDAQ, USD)
TVRD
1.63
+0.55 (+15.03%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
39.50M
Price/Sales
15.37
Ent value
29.89M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.67 |
| Daily high | 4.34 |
| Daily low | 3.63 |
| Daily Volume | 105K |
| All-time high | 42.98 |
| 1y analyst estimate | 8.86 |
| Beta | - |
| EPS (TTM) | -2.78 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TVRD | S&P500 | |
| Current price drop from All-time high | -96.21% | -2.08% |
| Highest price drop | -93.37% | -56.47% |
| Date of highest drop | 7 Apr 2026 | 9 Mar 2009 |
| Avg drop from high | -82.64% | -10.68% |
| Avg time to new high | 26 days | 12 days |
| Max time to new high | 145 days | 1805 days |
News
